Community Healthcare earnings date
Want to see CHCT full AI Analyst Report?
Community Healthcare (CHCT) Q3 2026 Earnings Report
CHCT Q3 2026 EPS Results
- Actual EPS
- $0.09
- Consensus EPS
- $0.09
- Beat/Miss
- Met expectations
- One Year Ago EPS
- $0.03
CHCT Q3 2026 Revenue Results
- Actual Revenue
- $32.44M
- Expected Revenue
- $31.26M
- Beat/Miss
- Beat by +$1.18M
- YoY Revenue Growth
- +4.37%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/03/2026
- Time
- After Close
- Conference Call
- Tuesday, November 3, 2026
Community Healthcare's next earnings date is estimated for February 16, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was broadly positive, supported by revenue, FFO, and AFFO growth; improved occupancy and leasing activity; lower G&A and well-controlled property expenses; successful capital recycling; a funded acquisition pipeline; and reduced leverage. The main challenges were persistent vacancies, delays in the behavioral hospital transaction and certain acquisitions, a modest increase in interest expense, and the absence of additional properties under contract.
Management expects 3 additional redevelopment projects to complete late in the fourth quarter or early in the first quarter, with leases projected to commence late in the first quarter or early in the second quarter of 2027; the 4 properties under definitive agreements have an aggregate expected purchase price of $99 million, expected returns of 9.1% to 9.75%, and are expected to close with the first in the fourth quarter, a second in the first quarter of '27 and the remaining 2 between mid-'27 and early '28. The company expects transaction activity to accelerate through 2027, believes G&A will consistently be lower year-over-year for the next few quarters, and said the numbers being shown are consistent and will continue to grow. It also said the 9% to 10% range is certainly achievable, including that mid-9 range, anywhere from 9% to 10%, for additional acquisition candidates.
- Occupancy Improvement and Robust Leasing ActivityPortfolio occupancy increased from 89.8% in the second quarter to 90.1% in the third quarter. Management reported robust leasing activity, a strong leasing pipeline, and continued execution toward its target occupancy.
- Redevelopment Projects AdvancingThe behavioral hospital redevelopment in Lafayette, Louisiana, commenced its lease early in the third quarter. Three additional redevelopment projects are under construction, with completion expected late in the fourth quarter or early in the first quarter, backed by long-term leases projected to commence late in the first quarter or early in the second quarter of 2027 after certificates of occupancy and licensure.
- Speculative Suite Program ExpansionThe company has one speculative suite under construction, one in permitting, and three in the design phase. The suites are positioned in high-demand buildings where tenants are seeking turnkey-ready space, and management said the program is intended to accelerate occupancy gains and NOI realization.
- Successful Capital Recycling and Disposition ProceedsThe company monetized one property in the third quarter and two additional properties in October, generating total net proceeds of $32.8 million. The largest transaction, an inpatient rehab facility, is expected to produce a $9.1 million gain in the fourth quarter. More than $30 million of properties are actively marketed for disposition.
- Acquisition Pipeline with Attractive Expected ReturnsThe company has signed definitive purchase and sale agreements for four properties to be acquired upon completion and occupancy, with an aggregate expected purchase price of $99 million. Expected returns range from 9.1% to 9.75%, with the first closing anticipated in the fourth quarter, the second in the first quarter of 2027, and the remaining two between mid-2027 and early 2028.
- Improved Geriatric Behavioral Hospital Rent CollectionsThe geriatric behavioral hospital operator leasing six properties paid approximately $540,000 in rent during the quarter, an increase of $170,000 from the second quarter. Management also said the underlying business is performing better than when the letter of intent was signed.
- Capital Availability and Disciplined LeverageThe company did not issue shares under its ATM program during the quarter and expects selected asset sales and revolver capacity to fund near-term acquisitions. Leverage decreased by 0.2x to 5.8x, while management reiterated its intention to maintain modest leverage levels.
- Stable DividendThe company declared a third-quarter dividend of $0.33 per common share, unchanged from the prior period, equivalent to an annualized dividend of $1.32 per share.
- Revenue GrowthTotal revenue increased from $31.1 million in the third quarter of 2025 to $32.4 million in the third quarter of 2026, representing 4.4% year-over-year growth. Revenue also increased 3.9% quarter-over-quarter from $31.2 million in the second quarter of 2026, driven by higher occupancy from leasing activity and acquisitions.
- Property Expense ControlProperty operating expenses were approximately $6 million in the third quarter, up only approximately $100,000 quarter-over-quarter. On a year-over-year basis, expenses increased by less than $50,000, or less than 1%, which management attributed to strong cost management.
- General and Administrative Expense ReductionThird-quarter G&A expense was $4.2 million, down approximately $700,000 quarter-over-quarter and approximately $470,000 year-over-year. Management expects G&A to remain consistently lower year-over-year for the next few quarters, while noting that quarterly fluctuations are typical.
- Funds from Operations GrowthThird-quarter FFO was $15 million, up 10.4% year-over-year from $13.5 million. Diluted FFO per common share increased from $0.50 to $0.54 year-over-year and from $0.48 in the second quarter, representing a 13.2% quarter-over-quarter increase in FFO.
- AFFO GrowthThird-quarter AFFO totaled $16 million, up 6.1% year-over-year from $15.1 million. AFFO per diluted common share increased from $0.56 to $0.58 year-over-year and rose 4% quarter-over-quarter from $0.56.
- Prospects for Additional Acquisition ActivityManagement said the market is offering compelling acquisition opportunities aligned with its quality and return objectives. It expects transaction activity to accelerate through 2027 and said returns in the 9% to 10% range, including the mid-9% range, are achievable.
CHCT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 16, 2027 | 2026 (Q4) | 0.14- | 0.51 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | 0.090.09 | 0.03 | 200.00% (+0.06) | |
| Aug 04, 2026 | 2026 (Q2) | 0.110.06 | -0.5 | 112.00% (+0.56) | |
| May 05, 2026 | 2026 (Q1) | ―0.07 | 0.03 | 133.33% (+0.04) | |
| Feb 17, 2026 | 2025 (Q4) | 0.110.51 | 0.04 | 1175.00% (+0.47) | |
| Oct 28, 2025 | 2025 (Q3) | 0.080.03 | 0.04 | -25.00% (-0.01) | |
| Jul 29, 2025 | 2025 (Q2) | -0.13-0.50 | -0.42 | -19.05% (-0.08) | |
| Apr 29, 2025 | 2025 (Q1) | 0.070.03 | 0.11 | -72.73% (-0.08) | |
| Feb 18, 2025 | 2024 (Q4) | 0.070.04 | 0.15 | -73.33% (-0.11) | |
| Oct 29, 2024 | 2024 (Q3) | 0.070.04 | 0.11 | -63.64% (-0.07) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

